Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation (Q80226796)
Jump to navigation
Jump to search
scientific article published on 26 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation |
scientific article published on 26 April 2007 |
Statements
Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation (English)
Aziz Karim
Zhen Zhao
Margaret Slater
Dawn Bradford
Jennifer Schuster